Rezdiffra is exceeding Wall Street’s expectations as the MASH market takes shapenews2026-05-11T18:27:48+00:00May 11th, 2026|Endpoints News|
Daiichi eyes almost $15B in oncology sales by 2030 in ADC franchise pushnews2026-05-11T15:35:21+00:00May 11th, 2026|Endpoints News|
CSL sinks to nine-year low on revenue warning, $5B write-downnews2026-05-11T10:30:09+00:00May 11th, 2026|Endpoints News|
Daiichi Sankyo posts ‘extraordinary loss’ of nearly $1Bnews2026-05-08T17:16:32+00:00May 8th, 2026|Endpoints News|
‘Pharma, not really’: Top young AI talent shuns careers at big drugmakersnews2026-05-08T13:09:49+00:00May 8th, 2026|Endpoints News|
Capricor sues Nippon Shinyaku over Duchenne drug ‘pricing flaw’ and launch prepnews2026-05-08T11:00:19+00:00May 8th, 2026|Endpoints News|
Amazon adds Ozempic pill to same-day prescription drug kiosksnews2026-05-07T17:15:46+00:00May 7th, 2026|Endpoints News|
Angelini fortifies neurology portfolio with $4.1B buyout of Catalystnews2026-05-07T10:40:10+00:00May 7th, 2026|Endpoints News|
Amgen, AbbVie say IRA negotiations impacted Q1 salesnews2026-05-06T19:05:40+00:00May 6th, 2026|Endpoints News|
Lilly plans new $4.5B manufacturing investment in Indiananews2026-05-06T18:25:24+00:00May 6th, 2026|Endpoints News|
